These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28351785)

  • 1. British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.
    Hurst JR; Verma N; Lowe D; Baxendale HE; Jolles S; Kelleher P; Longhurst HJ; Patel SY; Renzoni EA; Sander CR; Avery GR; Babar JL; Buckland MS; Burns S; Egner W; Gompels MM; Gordins P; Haddock JA; Hart SP; Hayman GR; Herriot R; Hoyles RK; Huissoon AP; Jacob J; Nicholson AG; Rassl DM; Sargur RB; Savic S; Seneviratne SL; Sheaff M; Vaitla PM; Walters GI; Whitehouse JL; Wright PA; Condliffe AM
    J Allergy Clin Immunol Pract; 2017; 5(4):938-945. PubMed ID: 28351785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
    Chase NM; Verbsky JW; Hintermeyer MK; Waukau JK; Tomita-Mitchell A; Casper JT; Singh S; Shahir KS; Tisol WB; Nugent ML; Rao RN; Mackinnon AC; Goodman LR; Simpson PM; Routes JM
    J Clin Immunol; 2013 Jan; 33(1):30-9. PubMed ID: 22930256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey.
    van de Ven AAJM; Alfaro TM; Robinson A; Baumann U; Bergeron A; Burns SO; Condliffe AM; Fevang B; Gennery AR; Haerynck F; Jacob J; Jolles S; Malphettes M; Meignin V; Milota T; van Montfrans J; Prasse A; Quinti I; Renzoni E; Stolz D; Warnatz K; Hurst JR
    Front Immunol; 2020; 11():606333. PubMed ID: 33324422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
    Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
    Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Granulomatous Lymphocytic Interstitial Lung Disease Using Two Scoring Systems for Computed Tomography Scans-A Retrospective Cohort Study.
    Meerburg JJ; Hartmann IJC; Goldacker S; Baumann U; Uhlmann A; Andrinopoulou ER; Kemner V/D Corput MPC; Warnatz K; Tiddens HAWM
    Front Immunol; 2020; 11():589148. PubMed ID: 33193417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
    Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
    Front Immunol; 2020; 11():617985. PubMed ID: 33584710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.
    Cinetto F; Scarpa R; Carrabba M; Firinu D; Lougaris V; Buso H; Garzi G; Gianese S; Soccodato V; Punziano A; Lagnese G; Tessarin G; Costanzo G; Landini N; Vio S; Bondioni MP; Consonni D; Marasco C; Del Giacco S; Rattazzi M; Vacca A; Plebani A; Fabio G; Spadaro G; Agostini C; Quinti I; Milito C
    Front Immunol; 2021; 12():627423. PubMed ID: 33777011
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency.
    Nishimura M; Miyata J; Tanigaki T; Nomura S; Serizawa Y; Igarashi S; Itou K; Ohno T; Kurata Y; Kimizuka Y; Fujikura Y; Sekinaka Y; Sekinaka K; Matsukuma S; Nonoyama S; Kawana A
    Intern Med; 2023 Mar; 62(6):871-875. PubMed ID: 35945007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
    Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
    BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoidosis and common variable immunodeficiency: similarities and differences.
    Verbsky JW; Routes JM
    Semin Respir Crit Care Med; 2014 Jun; 35(3):330-5. PubMed ID: 25007085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.
    Mannina A; Chung JH; Swigris JJ; Solomon JJ; Huie TJ; Yunt ZX; Truong TQ; Brown KK; Achcar RD; Olson AL; Cox CW; Kligerman SJ; Curran-Everett D; Fernández Pérez ER
    Ann Am Thorac Soc; 2016 Jul; 13(7):1042-9. PubMed ID: 27064856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
    Tashtoush B; Memarpour R; Ramirez J; Bejarano P; Mehta J
    Clin Respir J; 2018 Jan; 12(1):337-343. PubMed ID: 27243233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomatous-Lymphocytic Interstitial Lung Disease in a Patient With Common Variable Immunodeficiency.
    Shah JL; Amin SB; Verma N; Mohammed TL
    Curr Probl Diagn Radiol; 2018; 47(4):282-284. PubMed ID: 28583689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
    Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
    Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
    Fraz MSA; Michelsen AE; Moe N; Aaløkken TM; Macpherson ME; Nordøy I; Aukrust P; Taraldsrud E; Holm AM; Ueland T; Jørgensen SF; Fevang B
    J Clin Immunol; 2022 Oct; 42(7):1553-1563. PubMed ID: 35789314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Clinics, Laboratory, and Imaging for the Diagnosis of Common Variable Immunodeficiency-Related Granulomatous-Lymphocytic Interstitial Lung Disease.
    Cabanero-Navalon MD; Garcia-Bustos V; Forero-Naranjo LF; Baettig-Arriagada EJ; Núñez-Beltrán M; Cañada-Martínez AJ; Forner Giner MJ; Catalán-Cáceres N; Martínez Francés M; Moral Moral P
    Front Immunol; 2022; 13():813491. PubMed ID: 35281075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency.
    Bates CA; Ellison MC; Lynch DA; Cool CD; Brown KK; Routes JM
    J Allergy Clin Immunol; 2004 Aug; 114(2):415-21. PubMed ID: 15316526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency].
    Bianchi MP; Letovanec I; Spertini F; Nicod LP; Lazor R
    Rev Med Suisse; 2013 Nov; 9(407):2175-80. PubMed ID: 24354253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
    Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
    J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 18-year-old woman with Kabuki syndrome, immunoglobulin deficiency and granulomatous lymphocytic interstitial lung disease.
    De Dios JA; Javaid AA; Ballesteros E; Metersky ML
    Conn Med; 2012 Jan; 76(1):15-8. PubMed ID: 22372173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.